Skip to search formSkip to main contentSkip to account menu

LeGoo

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
......................................................................................................................................... 2 Acknowledgements ...................................................................................................................... 12 Funding Sources ........................................................................................................................... 13 Publications, Prizes and Presentations ........................................................................................ 14 Journal Publications ................................................................................................................. 14 Prizes ........................................................................................................................................ 14 Presentations ........................................................................................................................... 14 Abbreviations ............................................................................................................................... 16 List of Tables, Figures and Equations ........................................................................................... 20 Tables ........................................................................................................................................... 20 Figures .......................................................................................................................................... 20 Equations...................................................................................................................................... 25 1. Chapter 1; Introduction and Literature Review ................................................................... 26 1.1. Anatomy, physiology and pathophysiology of the lung and COPD ............................. 27 1.1.1. Anatomy of the lung............................................................................................. 27 1.1.2. Physiology of the lung .......................................................................................... 28 1.1.3. Chronic Obstructive Pulmonary Disease and its pathophysiology ...................... 30 1.2. Chronic Obstructive Pulmonary Disease today: management options and limitations 34 1.2.1. Pharmacotherapy ................................................................................................. 34 1.2.2. Lung volume reduction strategies ........................................................................ 36 1.2.3. Lung transplantation ............................................................................................ 39 1.3. Future approaches to COPD treatment – regenerative medicine (RM) and tissue engineering (TE) ....................................................................................................................... 39 1.3.1. Cell sources for potential use in respiratory regeneration .................................. 40 1.3.1.1. Endogenous stem cell populations of the respiratory tract ........................ 40 1.3.1.2. Exogenous stem cells for regenerative purposes: MSCs ............................. 41 1.3.2. Signalling factors for potential respiratory regeneration .................................... 45 1.3.2.1. Hepatocyte Growth Factor (HGF) ................................................................ 45 1.3.2.2. Bone Morphogenetic Protein 4 (BMP-4) ..................................................... 46 
2013
2013
BackgroundHydatid disease is caused by the tapeworm Echinococcus granulosus or Echinococcus multilocularis or Echinococcus Vogeli… 
2012
2012
During vascular surgical operations, there is a need for a simpler and more reliable method of temporary arterial occlusion than… 
2011
2011
Introduction: There is a need to develop methods of vascular hemostasis, which limit vessel trauma. LeGoo is a reverse… 
2010
2010
To evaluate the safety and efficacy of a novel, reverse thermo-sensitive polymer (LeGoo™) for its ability to provide temporary… 
2009
2009
Microvascular clamps have several potential shortcomings, including the risk of vessel injury. LeGoo, a novel reverse…